COVID-19 Vaccines Market Size, Share & Forecast to 2032

The COVID-19 Vaccines Market is evolving rapidly, where scientific innovation meets shifting supply chains and regulatory priorities. Decision-makers face new challenges requiring precise insights to sustain immunization programs and navigate policy, procurement, and technology advancements.

Market Snapshot

The COVID-19 Vaccines Market expanded from USD 260.10 billion in 2025 to USD 285.30 billion in 2026, progressing at a CAGR of 11.10% and is projected to reach USD 543.57 billion by 2032. This significant market growth reflects continued demand for variant-responsive vaccines, booster strategies, and scalable manufacturing. Shifting policies and dynamic segment performance highlight the importance of tailored approaches across all geographies and end-user groups.

Scope & Segmentation of the COVID-19 Vaccines Market

This report delivers comprehensive segmentation and strategic analysis to support executive planning and operational execution. Coverage includes:

Vaccine Technology: mRNA, inactivated, and protein subunit platforms—covering both adjuvanted and non-adjuvanted formulations, reflecting differentiated immune protection and manufacturing needs.
Dosing Strategies: Single-dose, two-dose, and booster regimens to address age, risk profiles, and adherence optimization.
Administration Routes: Intramuscular and intranasal delivery, accounting for population convenience and clinical efficacy considerations.
Packaging Formats: Prefilled syringes and vial options, balancing inventory control and minimizing wastage at point-of-care.
Distribution Channels: Clinic, hospital, and pharmacy routes, with the latter's increasing significance in booster deployment for adults and broader demographics.
Demographic Cohorts: Pediatric, adolescent, and adult segments, each informing dosage strength, communication, and deployment strategies.
Procurement Models: Public sector contracting and private purchase, encompassing governmental subsidies, reimbursement mechanisms, and hybrid frameworks.
Regional Dynamics: Americas, Europe, Middle East & Africa, and Asia-Pacific regions examined for differences in regulatory alignment, manufacturing capability, and distribution infrastructure.

Key Takeaways

Technological diversification is expanding strategic flexibility for manufacturers and health authorities, responding to new variants and evolving end-user needs.
Regulatory adaptation enables timely antigen and delivery profile updates while maintaining robust safety requirements for new vaccine formulations.
Segmentation intelligence aids targeted product development, addressing specific population profiles and optimizing channel strategies for efficient rollout.
Regional variance in infrastructure, regulatory coordination, and public health delivery shapes vaccine access, requiring localized approaches and robust public-private collaboration.
Strategic alliances—spanning manufacturers and contract organizations—enable scalable production and distributed supply, reducing operational and procurement risk for buyers.
Stakeholder engagement, transparent communication, and proactive policy alignment are essential for long-term trust and procurement continuity.

Tariff Impact on the COVID-19 Vaccines Market

Tariff adjustments implemented in 2025 added new layers of operational complexity to vaccine supply chains. These changes triggered reviews of manufacturing footprints, distribution models, and procurement risk strategies. Manufacturers adapted by pursuing local production for critical fill-finish steps, reducing tariff exposure through supplier diversification, and standardizing packaging to minimize cross-border transfer liabilities. Procurement agencies and health systems recalibrated sourcing frameworks, weighing the impact of tariffs alongside existing import exemptions. This evolving tariff landscape underscores the necessity of integrated risk assessment across regulatory and logistical functions.

Methodology & Data Sources

The COVID-19 Vaccines Market analysis is grounded in direct stakeholder interviews—including input from development leads, manufacturing managers, procurement officials, and healthcare providers—augmented by regulatory reviews and operational studies. Data triangulation across primary engagement, peer-reviewed publications, and regional case studies ensured robust, actionable intelligence guiding segmentation and strategic planning.

Why This Report Matters

Enables executives to assess risk and optimize vaccine supply chains under changing policy and procurement dynamics.
Delivers practical, evidence-based recommendations to inform product innovation, commercialization, and stakeholder collaboration.
Offers a unified reference for adapting vaccine platform strategy and delivery logistics in response to global public health priorities.

Conclusion

The COVID-19 Vaccines Market will remain defined by the interplay of scientific advancement, agile operations, and policy foresight. Senior leaders equipped with integrated market intelligence can prioritize adaptability, operational integrity, and equitable vaccine delivery in this evolving environment.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. COVID-19 Vaccines Market, by Vaccine Technology

8.1. Inactivated
8.2. mRNA
8.3. Protein Subunit
8.3.1. Adjuvanted
8.3.2. Non Adjuvanted

9. COVID-19 Vaccines Market, by Dosage Regimen

9.1. Booster Dose
9.2. Single Dose
9.3. Two Dose

10. COVID-19 Vaccines Market, by Packaging Type

10.1. Prefilled Syringe
10.2. Vial

11. COVID-19 Vaccines Market, by Application Route

11.1. Intramuscular
11.2. Intranasal

12. COVID-19 Vaccines Market, by Distribution Channel

12.1. Clinic
12.2. Hospital
12.3. Pharmacy

13. COVID-19 Vaccines Market, by End User

13.1. Adolescent
13.2. Adult
13.3. Child

14. COVID-19 Vaccines Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. COVID-19 Vaccines Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. COVID-19 Vaccines Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States COVID-19 Vaccines Market
18. China COVID-19 Vaccines Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AIVITA Biomedical Inc.
19.6. AstraZeneca Plc
19.7. Baseimmune Ltd.
19.8. Bharat Biotech International Ltd.
19.9. Biological E. Ltd.
19.10. CanSino Biologics Inc.
19.11. Centivax Inc.
19.12. Codagenix Inc.
19.13. CureVac SE
19.14. Dr. Reddy's Laboratories Ltd.
19.15. Emergex Vaccines Holding Ltd.
19.16. Etherna Immunotherapies Nv
19.17. Gennova Biopharmaceuticals Ltd.
19.18. GlaxoSmithKline plc.
19.19. HDT Bio, Inc.
19.20. Meissa Vaccines, Inc.
19.21. Merck & Co., Inc.
19.22. Moderna, Inc.
19.23. Novavax Inc.
19.24. Osivax SAS
19.25. Pfizer Inc.
19.26. Providence Therapeutics Inc.
19.27. SANOFI
19.28. Serum Institute of India Pvt. Ltd.
19.29. Sinovac Biotech Ltd.
19.30. Vaccitech PLC
19.31. Zydus Lifesciences Ltd.

List of Figures

FIGURE 1. GLOBAL COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COVID-19 VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COVID-19 VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COVID-19 VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COVID-19 VACCINES MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COVID-19 VACCINES MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COVID-19 VACCINES MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADJUVANTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADJUVANTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADJUVANTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COVID-19 VACCINES MARKET SIZE, BY NON ADJUVANTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COVID-19 VACCINES MARKET SIZE, BY NON ADJUVANTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COVID-19 VACCINES MARKET SIZE, BY NON ADJUVANTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COVID-19 VACCINES MARKET SIZE, BY BOOSTER DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COVID-19 VACCINES MARKET SIZE, BY BOOSTER DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COVID-19 VACCINES MARKET SIZE, BY BOOSTER DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COVID-19 VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COVID-19 VACCINES MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COVID-19 VACCINES MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COVID-19 VACCINES MARKET SIZE, BY TWO DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COVID-19 VACCINES MARKET SIZE, BY TWO DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COVID-19 VACCINES MARKET SIZE, BY TWO DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COVID-19 VACCINES MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COVID-19 VACCINES MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COVID-19 VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COVID-19 VACCINES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COVID-19 VACCINES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COVID-19 VACCINES MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADOLESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADOLESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COVID-19 VACCINES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CHILD, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CHILD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COVID-19 VACCINES MARKET SIZE, BY CHILD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COVID-19 VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS COVID-19 VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. EUROPE COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 99. EUROPE COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 100. EUROPE COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. EUROPE COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. AFRICA COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AFRICA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 115. AFRICA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 116. AFRICA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 117. AFRICA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 118. AFRICA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. AFRICA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL COVID-19 VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. ASEAN COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 132. ASEAN COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 133. ASEAN COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 135. ASEAN COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. ASEAN COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GCC COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GCC COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. GCC COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 140. GCC COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 141. GCC COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 142. GCC COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 143. GCC COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. GCC COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. BRICS COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. BRICS COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 156. BRICS COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 157. BRICS COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRICS COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 159. BRICS COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. BRICS COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. G7 COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. G7 COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. G7 COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 164. G7 COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 165. G7 COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 166. G7 COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 167. G7 COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. G7 COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. NATO COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. NATO COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. NATO COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 172. NATO COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 173. NATO COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 174. NATO COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 175. NATO COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. NATO COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL COVID-19 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. CHINA COVID-19 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. CHINA COVID-19 VACCINES MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. CHINA COVID-19 VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, 2018-2032 (USD MILLION)
TABLE 189. CHINA COVID-19 VACCINES MARKET SIZE, BY DOSAGE REGIMEN, 2018-2032 (USD MILLION)
TABLE 190. CHINA COVID-19 VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA COVID-19 VACCINES MARKET SIZE, BY APPLICATION ROUTE, 2018-2032 (USD MILLION)
TABLE 192. CHINA COVID-19 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. CHINA COVID-19 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this COVID-19 Vaccines market report include:

AIVITA Biomedical Inc.
AstraZeneca Plc
Baseimmune Ltd.
Bharat Biotech International Ltd.
Biological E. Ltd.
CanSino Biologics Inc.
Centivax Inc.
Codagenix Inc.
CureVac SE
Dr. Reddy's Laboratories Ltd.
Emergex Vaccines Holding Ltd.
Etherna Immunotherapies Nv
Gennova Biopharmaceuticals Ltd.
GlaxoSmithKline plc.
HDT Bio, Inc.
Meissa Vaccines, Inc.
Merck & Co., Inc.
Moderna, Inc.
Novavax Inc.
Osivax SAS
Pfizer Inc.
Providence Therapeutics Inc.
SANOFI
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Vaccitech PLC
Zydus Lifesciences Ltd.

Table Information

Report Attribute	Details
No. of Pages	186
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 285.3 Billion
Forecasted Market Value ( USD ) by 2032	$ 543.57 Billion
Compound Annual Growth Rate	11.1%
Regions Covered	Global
No. of Companies Mentioned	28

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3505EUR$3,939USD£3,044GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3781EUR$4,249USD£3,283GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5125EUR$5,759USD£4,450GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6201EUR$6,969USD£5,385GBP

COVID-19 Vaccines Market - Global Forecast 2026-2032

Market Snapshot

Scope & Segmentation of the COVID-19 Vaccines Market

Key Takeaways

Tariff Impact on the COVID-19 Vaccines Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot

Scope & Segmentation of the COVID-19 Vaccines Market

Key Takeaways

Tariff Impact on the COVID-19 Vaccines Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

COVID-19 Vaccines - Global Strategic Business Report

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report by Type (Viral, Bacterial, Combination), Infection (COVID-19, Influenza), Age Group, Distribution Channel, and Region with Growth Forecasts, 2025-2030

Covid-19 and Vaccine Nationalism. Managing the Politics of Global Pandemics

2025 Global Forecast for Vpm1002 (Tuberculosis Bcg Based Vaccine) For Prevent Covid-19 Market (2026-2031): High Tech Outlook Report

Adult Vaccines Market - Global Forecast 2026-2032

About the COVID 19 Vaccine Market